MoonLake Immunotherapeutics MLTX Operating Lease Weighted Average Discount Rate Percent
Operating Lease Weighted Average Discount Rate Percent at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's operating lease weighted average discount rate percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's operating lease weighted average discount rate percent?
- MoonLake Immunotherapeutics (MLTX) reported operating lease weighted average discount rate percent of $0.06 in Q1 2026.
- How has MoonLake Immunotherapeutics's operating lease weighted average discount rate percent changed year-over-year?
- MoonLake Immunotherapeutics's operating lease weighted average discount rate percent increased by 36.2% year-over-year, from $0.05 to $0.06.
- What is the long-term trend for MoonLake Immunotherapeutics's operating lease weighted average discount rate percent?
- Over 2 years (2023 to 2025), MoonLake Immunotherapeutics's operating lease weighted average discount rate percent has grown at a -3.1% compound annual growth rate (CAGR), from $0.05 to $0.05.